Vical Incorporated Stock Nasdaq

Stocks

28/01/25	Fresh Tracks Therapeutics Announces Special Distribution	CI
16/03/24	Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
21/12/23	Fresh Tracks Therapeutics, Inc.(OTCPK:FRTX) dropped from S&P TMI Index	CI
18/12/23	Fresh Tracks Therapeutics, Inc.(OTCPK:FRTX) dropped from NASDAQ Composite Index	CI
13/11/23	Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
20/09/23	Wall Street Set to Open Wednesday Trading Higher as Investors Await Fed Decision on Interest Rates	MT
20/09/23	US Futures Rise Modestly Pre-Bell as Investors Await Fed Rate Decision	MT
20/09/23	Top Premarket Gainers	MT
20/09/23	Fresh Tracks Therapeutics' Board Approves Liquidation Plan; Shares Rise After Hours	MT
20/09/23	Fresh Tracks Therapeutics, Inc. Announces Chief Executive Officer Changes	CI
20/09/23	Fresh Tracks Therapeutics, Inc. Announces Executive Changes	CI
12/08/23	Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
26/07/23	Fresh Tracks Therapeutics, Inc. Announces Resignation of Robert B. Brown from the Board of Directors, Effective Immediately	CI

14/11/22	Oppenheimer Adjusts Fresh Tracks Therapeutics Price Target to $4 From $9, Maintains Outperform Rating	MT
27/09/22	Oppenheimer Adjusts Price Target on Fresh Tracks Therapeutics to $9 From $1, Maintains Outperform Rating	MT
16/08/22	HC Wainwright Adjusts Brickell Biotech's Price Target to $4.50 From $2, Keeps Buy Rating	MT
14/05/22	Lake Street Downgrades Brickell Biotech to Hold From Buy, Lowers Price Target to $0.25 From $2	MT
13/05/22	Oppenheimer Adjusts Brickell Biotech's Price Target to $1 From $4, Maintains Outperform Rating	MT

26/02/25	Fresh Tracks Therapeutics Announces Dissolution, Initial Cash Distribution and Termination of Trading on the OTC Pink Market	PR
29/01/25	Fresh Tracks Therapeutics Announces Appointment of Custodian and Planned Distribution	AQ
28/01/25	/C O R R E C T I O N -- Fresh Tracks Therapeutics, Inc./	PR
06/12/24	Fresh Tracks Therapeutics Announces Hearing Date and Notice of Proposed Consent Judgement Regarding Dissolution of Company	PR
18/06/24	Fresh Tracks Therapeutics Announces Delaware Petition Filed Seeking Appointment of Custodian for Eventual Dissolution of Company	AQ

09/03/23	MÄRKTE USA/Uneinheitlich - Zinspfad ungewiss
09/03/23	MÄRKTE USA/Uneinheitlich - Zinssorgen bleiben präsent
08/03/23	MÄRKTE USA/Wall Street mit leichter Erholung
08/03/23	MÄRKTE USA/Wall Street stabilisiert nach Vortagesverlusten
08/03/23	MARKT USA/Wall Street stabilisiert nach Vortagesverlusten

1 day

+2.11%

Manager	Title	Age	Since
Albert Marchio CEO	Chief Executive Officer	74	02/10/2023
Nancy Seretta CTO	Chief Tech/Sci/R&D Officer	-	01/01/2016
Aaron Fox-Collis DFI	Director of Finance/CFO	-	01/06/2022

Director	Title	Age	Since
Albert Marchio CHM	Chairman	74	02/10/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VICAL INCORPORATED	+2.11%	-3.76%	-	-	5.59M
WUXI APPTEC CO., LTD.	-0.70%	+13.34%	+75.61%	+103.83%	70.85B
ARGENX SE	-2.35%	+2.88%	+35.39%	+64.72%	55.41B
INSMED INCORPORATED	-1.62%	+34.25%	+17.43%	+491.04%	29.43B
WUXI BIOLOGICS (CAYMAN) INC.	+0.17%	+13.84%	+56.43%	+8.67%	24.12B
BIONTECH SE	0.00%	+1.59%	-15.06%	-13.21%	23.31B
GENMAB A/S	+0.05%	+6.12%	+46.81%	-21.81%	18.37B
PHARMAESSENTIA CORPORATION	+9.77%	+20.16%	+260.17%	+472.38%	16.99B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+0.09%	+7.97%	+31.57%	+627.40%	16.1B
EXELIXIS, INC.	-3.08%	-8.34%	+37.21%	+138.52%	13.12B
Average	+0.52%	+391.85%	+60.62%	+207.95%	29.75B
Weighted average by Cap.	-0.30%	+350.76%	+56.47%	+167.49%